Effect of GLP1R agonists taspoglutide and liraglutide on primary thyroid C-cells from rodent and man.

Boess, Franziska; Bertinetti-Lapatki, Cristina; Zoffmann, Sannah; George, Catherine; Pfister, Thomas; Roth, Adrian; Lee, Serene M L; Thasler, Wolfgang E; Singer, Thomas; Suter, Laura

Boess, Franziska; Bertinetti-Lapatki, Cristina; Zoffmann, Sannah; George, Catherine; Pfister, Thomas; Roth, Adrian; Lee, Serene M L; Thasler, Wolfgang E; Singer, Thomas; Suter, Laura.

Affiliation

Boess F; F. Hoffmann-La Roche Ltd., Non Clinical Safety, Grenzacherstrasse 124, 4070 Basel, Switzerland. franziska.boess@roche.com

J Mol Endocrinol ; 50(3): 325-36, 2013 Jun.

Article in En | MEDLINE | ID: mdl-23463748

Subject(s)

Glucagon-Like Peptide 1/analogs & derivatives; Peptides/pharmacology; Receptors, Glucagon/agonists; Thyroid Gland/cytology; Animals; Calcitonin/metabolism; Cells, Cultured; Glucagon-Like Peptide 1/pharmacology; Glucagon-Like Peptide-1 Receptor; Humans; Immunohistochemistry; In Situ Hybridization; Liraglutide; Rats; Triiodothyronine/metabolism

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Database: MEDLINE Main subject: Peptides / Thyroid Gland / Receptors, Glucagon / Glucagon-Like Peptide 1 Limits: Animals / Humans Language: En Year: 2013 Type: Article

Fulltext

XML

PubMed Links

Search on Google